Navigation Links
Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
Date:7/25/2012

NEWARK, N.J., July 25, 2012 /PRNewswire/ -- Actinium Pharmaceuticals Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that the Company made a regulatory milestone payment to Abbott Biotherapeutics Corp. following the launch of Actinium's multi-center Phase I/II clinical trial in acute myeloid leukemia (AML).  Acute Myeloid Leukemia is the most difficult form of leukemia to treat.  The majority of patients do not qualify for the commonly used chemotherapy regimen and their median survival following diagnosis is about two months without treatment.  The drug candidate being developed in this trial is Actimab-A, a construct developed using Lintuzumab, the monoclonal antibody licensed from Abbott Biotherapeutics Corp., formerly PDL, and Actinium's proprietary patented technology to deliver high doses of alpha irradiation directly to cancer cells while largely sparing healthy tissues.

"This payment reflects the significant progress our company has made over the last six months," said Dragan Cicic, MD, the CEO of Actinium Pharmaceuticals Inc.  "In addition to having successfully started our first multi-center trial, Actinium Pharmaceuticals is moving ahead with trial expansion and adding new product candidates.  We remain on track in our development plan and look forward to continuing to report further strategic milestones."

Under the terms of the Abbott Biotherapeutics license, Actinium Pharmaceuticals makes payments to Abbott Biotherapeutics when certain key regulatory milestones are reached and will also make royalty payments on the sales of Actimab-A. 

About Actimab-A

Actimab-A is a drug candidate construct made using Actinium Pharmaceuticals' proprietary patented technology for arming monoclonal antibodies with alpha emitters actinium 225 and bismuth 213.  Antibodies are used as high precision delivery systems that bring powerful alpha
'/>"/>

SOURCE Actinium Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Diplomat, the ... as one of two winners in the 2014 ... Pharmacy Solutions, LLC. The results of the competition ... Specialty Pharmacy News. Diplomat was ... University Education & Training program. Through Diplomat University, ...
(Date:8/22/2014)... 2014 Research and Markets  has announced ... Opportunities, Tools & Technologies" report to their offering. ... research products or you wish to expand your product ... market is. The authors know you want to make ... scientists, to generate improved revenues and take market share ...
(Date:8/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The intravenous ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Global and Chinese Intravenous Catheter Industry Report 2014 2
... Cell Therapeutics, Inc. (the "Company") (NASDAQ and MTA: CTIC) ... "Board") approved a reverse stock split following the Company,s ... non-compliance from the staff of The NASDAQ Stock Market ... not regained compliance with NASDAQ Listing Rule 5550(a)(2) because ...
... Talnadge, a power wheelchair provided through Medicare is the ... to visit with friends and engage in the community, ... Those starkly different living environments are the only ... from muscular dystrophy and spina bifida.  These medical conditions ...
Cached Medicine Technology:Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing 2Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing 3Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing 4Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 2Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 3Power Wheelchairs Keep Medicare Beneficiaries Out of Nursing Homes, While Reducing Government Costs and Providing More Freedom and Independence 4
(Date:8/23/2014)... Board of Directors voted on Monday, August 18th to approve ... for commercial and industrial properties. This was accomplished with ... in Carmel, California. , This is a historical moment, ... the State of California has approved this technology for use ... can now be used as a sole source of water ...
(Date:8/23/2014)... 23, 2014 Dealing with a drug or ... when the addict is a child. Adolescent addiction has been ... long time, but a new helpline is now providing a ... parents to find a real addiction recovery center. , The ... positive impact in the community. By calling (404) 975-2762, parents ...
(Date:8/23/2014)... vacation is almost over and before we know it schools ... school supplies and a new wardrobe might take precedence over ... also spend some time brushing up on bed bug prevention ... heavily populated places,” said Randy Rupert, Bed Bug Team Lead ... for bed bugs to take up residence.” , An already ...
(Date:8/22/2014)... On Friday, Aug. 22, Liberty University ... Sciences , hosting a ceremony in its courtyard attended ... and public welfare. , The 162-member inaugural class of ... (LUCOM) joined Liberty staff, faculty, and community leaders in ... new medical school. Classes began on Monday, Aug. 4. ...
(Date:8/22/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has ... highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ) and BlueHost ... 10 Best SEO Hosting states, “It is hard ... Actually, these companies have outperformed their competitors on ... People can get the best web hosting at ...
Breaking Medicine News(10 mins):Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 4Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2
... undertaken by a group of Spanish scientists, amongst which ... of Navarra and the Centre for Applied Medical Research// ... new line of treatment for patients with acute lymphoblastic ... been published in the official journal, Blood, of the ...
... is an independent risk factor for HIV infection, according ... of Sexually Transmitted Infections. The researchers conducted// a meta-analysis ... studies looking at the link between smoking and progression ... ,There is a growing recognition that smoking can ...
... are most likely to gain weight, a new study says//. ... aged nine and 10 and followed them for at least a ... cholesterol every year through age 18, then had the teens report ... the girls were white and half were black. ,The ...
... According to a recent study led by John-Dylan Haynes, ... cortex as subjects// concentrated on their choice of two ... activity patterns that correspond to the subjects' different plans. ... group led by John-Dylan Haynes of the Max Planck ...
... now for Trevis Smith, once- upon- a -time hero of Regina//. ... aggravated sexual assault last Thursday. , The 31-year-old football ... trial, which has been going on for some time. ... term of minimum two years and maximum, life. ,Two ...
... checkup in pregnant women to get underway soon//. ... mandatory in pregnant women, even if no symptoms of the ... slightly under active or a hyperactive thyroid gland during pregnancy ... lower IQ's. ,2-5 percent of women in general ...
Cached Medicine News:Health News:A New Treatment Discovered For Acute Lymphoblastic Leukemia 2Health News:Smoking Increases Risk of HIV Acquisition 2Health News:Adolescent Girls More Likely to Gain Weight: Study 2Health News:Reading Hidden Intentions in Brain 2Health News:Pregnant? Check Your Thyroid Secretion! 2
... Provides a more occlusive wrap than ... where wound transudate must be contained. Predictable ... be inert, nonantigenic, and nonpyrogenic. ,VICRYL (polyglactin ... synthetic absorbable copolymer of glycolide and lactide, ...
Used for implantation to reinforce soft tissue. Supplied sterile in peel-open packages. Intended for one-time use....
... mesh onlays are pre-cut and pre-shaped to ... are more frequently done. These pre-shaped onlays ... ProLite Ultra and are designed for use ... in both small and large sizes, they ...
... such as laparoscopic inguinal hernia repair ... a surgical biomaterial that enables rapid ... provides the answer to the most ... Made from strong, soft, inert and ...
Medicine Products: